The usual biotech metric of ‘how many AI drugs are in the clinic?’ misses the pointIn a time of relentless AI hype and mounting global economic uncertainty, the real winners will be those who think long-term. One of the most transformative opportunities lies in building AI that can decode biology, promising not just massive returns, […]
